Yale tests blood pressure drug to curb alcohol cravings
NCT ID NCT03764098
Summary
This study is testing whether guanfacine, a medication typically used for high blood pressure and ADHD, can help people with alcohol use disorder reduce their drinking. Researchers will give 160 participants either the medication or a placebo pill and measure how much alcohol they choose to drink in lab sessions and during a 6-week treatment period. The goal is to see if the drug helps control drinking urges, especially those triggered by stress or stimulation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale University School of Medicine
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.